SEC Form 4 · accession 0001209191-15-057563
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan L. Kelley
Director
Period of report
Jun 26, 2015
Accepted (ET)
Jun 30, 2015 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.78 | Jun 26, 2015 | A | 7,000 | A | — | Jun 25, 2025 | Common Stock | 7,000 | 7,000 | D |
| Stock Option (Right to Buy)F2 | $4.78 | Jun 26, 2015 | A | 11,000 | A | — | Jun 25, 2025 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1This option was granted June 26, 2015. The shares underlying this option vest in three equal annual installments on October 3, 2015, October 3, 2016 and October 3, 2017, respectively.
- F2This option was granted on June 26, 2015. The shares vest in full on the earlier of June 26, 2016 or immediately prior to the Corporation's 2016 annual meeting of stockholders, subject to Dr. Kelley's continued service as a director of the Corporation through such date.